<table border="1"><tr><th>IUPAC nomenclature</th><td><ul><li>7-chloro-1-methyl-5-phenyl-3 | H | -1,4-benzodiazepine-2-one</li></ul></td></tr><tr><th>Identification</th><td><ul><li>CAS Registry | 439-14-5 | ATC Code | N05 | BA01 | PubChem | 3016 | Drumbank | DB00829 | ChemSpider | 2908.</li></ul></td></tr><tr><th>Chemical properties.</th><td><ul><li>Chemical | C | 16 | H | 13 | Cl | N | 2 | O | Molecular mass | 284.7 g/mol | SMILES | eMolecules | &amp; | PubChem</li></ul></td></tr><tr><th>Drug dynamics.</th><td><ul><li>Biocompatibility | 76% (64-97%) oral, 81% (62-98%) rectal; n=6 | Drug dosage | liver:CYP2B6 (minor route) to en:desmethyldiazepam, en:CYP2C19 (major route) to inactive metabolites, en:CYP3A4 (major route) to desmethyldiazepam | Biological response | 20-100 hours (36-200 hours for main active metabolite desmethyldiazepam) | Emission | Kidney</li></ul></td></tr><tr><th>Prescription Recommendations</th><td><ul><li>Authorization Information | U.S. Food and Drug Administration | Home Page | Contraceptive Safety | C | (Australia) | D | (U.S.) | Legal Status | Prescription Requirement (S4) | (Australia) | Schedule IV | (Canada) | Class C | (United Kingdom) | Schedule IV | (U.S.) |  P | rescription only | addictive tendencies | Moderate | dosing method | by mouth, IM, IV, left</li></ul></td></tr></table>